Information

26.03.2020

Election of the Swissmedic Medicines Expert Committees (SMEC) for the 2021-2024 term of office

Independent experts as an additional quality-assurance element in the authorisation process

25.02.2020

International cooperation on therapeutic products

Swissmedic authorises a new active substance (NAS) under the ACSS Consortium initiative for the first time

01.02.2020

Guidance document Authorisation according to Art. 14 para. 1 abis-quater TPA HMV4 updated

The new version of the guidance document enters into force on 1 February 2020.

20.01.2020

Notes on using Swissmedic templates for Information for healthcare professionals and Patient information

There are two versions of Swissmedic's templates for Information for healthcare professionals and Patient information for human medicinal products

15.01.2020

Updating of guidance document on authorisation of human medicinal products under Art. 13 TPA HMV4

Changed procedure for "Justified cases" pursuant to Art. 18 para. 2 TPO

19.12.2019

Adaptation of the strategic document SMEC Code

ZL003_00_001de_SD

01.12.2019

Modification of various documents relating to authorisation

ZL000_00_024e_WL / ZL101_00_007e_WL / ZL300_00_001e_WL